Search

Your search keyword '"Czene K."' showing total 602 results

Search Constraints

Start Over You searched for: Author "Czene K." Remove constraint Author: "Czene K." Language english Remove constraint Language: english
602 results on '"Czene K."'

Search Results

2. FANCM missense variants and breast cancer risk

3. Impact of parental cancer on IQ, stress resilience, and physical fitness in young men

4. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in similar to 200,000 patients (vol 24, 69, 2022)

6. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

7. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

9. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

10. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

11. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

12. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

13. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

14. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

15. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

16. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

17. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

18. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

22. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

23. Two truncating variants in FANCC and breast cancer risk

24. Genome-wide association study of germline variants and breast cancer-specific mortality

25. Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

26. Genome-wide association study of germline variants and breast cancer-specific mortality

27. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

28. Assessment of Long-term Distant Recurrence-Free Survival Associated with Tamoxifen Therapy in Postmenopausal Patients with Luminal A or Luminal B Breast Cancer

29. Technological readiness and implementation of genomic‐driven precision medicine for complex diseases.

31. DNA mismatch repair gene MSH6 implicated in determining age at natural menopause

32. Identification of nine new susceptibility loci for endometrial cancer

33. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

34. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

35. Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium\ud

36. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

37. Gene-environment interactions involving functional variants

41. Body mass index and breast cancer survival:a Mendelian randomization analysis

42. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

43. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

44. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

45. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

46. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

47. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

48. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

49. Five endometrial cancer risk loci identified through genome-wide association analysis

50. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Catalog

Books, media, physical & digital resources